NTRK1 and B-cell chronic lymphocytic leukemia: In particular, we focused our attention on its potential effect on CCL17, CD40 and PI3KCD mRNAs, which are biologically relevant to CLL, and on DDR1 mRNA that encodes a tyrosine kinase receptor expressed in several tumors and leukemias [44].